Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. It has been reported to reduce the rate of relapses in…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Fingolimod.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Fingolimod shows recurring relationship patterns in the source. For example, Fingolimod → Chinese, Elimination, First, FTY720, Isaria, ISP-1, ISP-I, ISP-I-28, Myriocin, SAR, Showing, Structure, Yoshitomi Pharmaceuticals Another extracted example is Fingolimod → CD8, Isaria, ISP-1, It, Phospho-fingolimod, S1P, S1PR1, The, This, Unphosphorylated. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
multiple sclerosis drug also myriocin gilenya patients treatment reported used receptor lymphocytes may skin approved brain risk effective generic patent
TTTA extracted 63 structured relationships around Fingolimod. Examples in this analysis include Fingolimod → 3D model (JSmol) → Interactive image and Fingolimod → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Fingolimod | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Fingolimod | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Fingolimod | ATC code | L04AE01 (WHO) | 1.00 | infobox |
| Fingolimod | CAS Number | 162359-55-9 N | 1.00 | infobox |
| Fingolimod | ChEBI | CHEBI:63115 N | 1.00 | infobox |
| Fingolimod | ChEMBL | ChEMBL314854 Y | 1.00 | infobox |
| Fingolimod | ChemSpider | 97087 Y | 1.00 | infobox |
| Fingolimod | CompTox Dashboard (EPA) | DTXSID40167363 | 1.00 | infobox |
| Fingolimod | Drug class | Immunosuppressants | 1.00 | infobox |
| Fingolimod | DrugBank | DB08868 N | 1.00 | infobox |
| Fingolimod | Formula | C19H33NO2 | 1.00 | infobox |
| Fingolimod | IUPHAR/BPS | 2407 | 1.00 | infobox |
| Fingolimod | KEGG | D10001 N | 1.00 | infobox |
| Fingolimod | KEGG | as HCl: D04187 | 1.00 | infobox |
| Fingolimod | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Fingolimod | Legal status | CA: ℞-only | 1.00 | infobox |
| Fingolimod | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Fingolimod | Legal status | US: ℞-only | 1.00 | infobox |
| Fingolimod | Legal status | EU: Rx-only | 1.00 | infobox |
| Fingolimod | License data | US DailyMed: Fingolimod | 1.00 | infobox |
| Fingolimod | MedlinePlus | a611006 | 1.00 | infobox |
| Fingolimod | Molar mass | 307.478 g·mol−1 | 1.00 | infobox |
| Fingolimod | Pregnancy category | AU: D | 1.00 | infobox |
| Fingolimod | PubChem CID | 107970 | 1.00 | infobox |
| Fingolimod | Routes of administration | By mouth | 1.00 | infobox |
| Fingolimod | Trade names | Gilenya | 1.00 | infobox |
| Fingolimod | UNII | 3QN8BYN5QF | 1.00 | infobox |
| Fingolimod | causes | the internalization of S1P receptors | 0.90 | text |
| Fingolimod | is a | sphingosine-1-phosphate receptor modulator | 0.90 | text |
The concept neighborhoods around Fingolimod bring nearby vocabulary together. In this analysis, examples include Also, Multiple and Sclerosis. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Fingolimod, one of the stronger structural bridges in this analysis connects Fingolimod with Structure and mechanism. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Fingolimod to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Fingolimod · EN edition · Analysis: TopicsToTalkAbout